Pro-tumorigenic activity of PYCR1 in gastric cancer through regulating the PI3K/AKT signaling

Bibliographic Details
Title: Pro-tumorigenic activity of PYCR1 in gastric cancer through regulating the PI3K/AKT signaling
Authors: Huijie Xiao, Jiannan Huang, Haitao Wu, YuYing Li, Yizhuo Wang
Source: Heliyon, Vol 10, Iss 5, Pp e26883- (2024)
Publisher Information: Elsevier, 2024.
Publication Year: 2024
Collection: LCC:Science (General)
LCC:Social sciences (General)
Subject Terms: Pyrroline-5-carboxylate reductase 1, Gastric cancer, Proliferation, Metastasis, Prognosis, Science (General), Q1-390, Social sciences (General), H1-99
More Details: Background: The primary objective of this investigation was to assess the impact of pyrroline-5-carboxylate reductase 1 (PYCR1) on the progression of gastric cancer (GC), specifically focusing on tumor growth and metastatic potential. Methods: Surgical specimens from patients with different stages of GC were assayed for PYCR1 expression using immunohistochemistry. PYCR1 expression was manipulated by depletion or overexpression approaches in GC cells, and these cells were applied to explore the functional roles of PYCR1. Expression of apoptosis– and metastasis–related markers was quantified through quantitative real-time PCR and Western blot. Results: Higher PYCR1 expression was ascertained in surgical specimens from patients with GC as compared to noncancerous adjacent tissues. Additionally, PYCR1 overexpression in GC tissues was linked to adverse clinical outcomes. The depletion of PYCR1 in GC cells resulted in a pronounced reduction in proliferation, the induction of apoptosis, and the attenuation of invasion and metastasis. Conversely, its ectopic expression notably augmented proliferation, restricted apoptosis, and stimulated invasion and metastasis. In addition, the knockdown of PYCR1 resulted in a significant elevation in the activation of caspase 3, a key protein involved in apoptosis. This depletion also led to a decrease in the activation or expression of proteins associated with metastasis, such as phosphorylated (p)-phosphatidylinositol 3-kinase (PI3K), p-AKT serine/threonine kinase (AKT), and snail family transcriptional repressor 1 (Snail). Additionally, it resulted in an upregulation of E-cadherin expression. Conversely, the overexpression of PYCR1 notably increased the levels of p-PI3K, p-AKT, and Snail, while simultaneously reducing E-cadherin expression. Conclusion: PYCR1, by activating PI3K/AKT signaling, assumes a crucial role in governing malignant characteristics of GC cells, including proliferation, apoptosis, and metastasis. These findings underscore the promising potential of PYCR1 as a diagnostic biomarker and a target for tailored therapeutic interventions in patients with GC.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2405-8440
Relation: http://www.sciencedirect.com/science/article/pii/S2405844024029141; https://doaj.org/toc/2405-8440
DOI: 10.1016/j.heliyon.2024.e26883
Access URL: https://doaj.org/article/f37000c8c0cd492f8aa40e1126e5d423
Accession Number: edsdoj.f37000c8c0cd492f8aa40e1126e5d423
Database: Directory of Open Access Journals
More Details
ISSN:24058440
DOI:10.1016/j.heliyon.2024.e26883
Published in:Heliyon
Language:English